WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012101125) SPECIFIC ANTIBODIES AGAINST HUMAN CXCL4 AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/101125    International Application No.:    PCT/EP2012/051056
Publication Date: 02.08.2012 International Filing Date: 24.01.2012
IPC:
C07K 16/24 (2006.01), A61K 39/395 (2006.01)
Applicants: INSERM (Institut National de la Santé et de la Recherche Médicale) [FR/FR]; 101 rue de Tolbiac F-75013 Paris (FR) (For All Designated States Except US).
BIKFALVI, Andreas [FR/FR]; (FR) (For US Only)
Inventors: BIKFALVI, Andreas; (FR)
Agent: HIRSCH, Denise; 7 rue Watt F-75013 Paris (FR)
Priority Data:
11305068.6 24.01.2011 EP
61/436,646 27.01.2011 US
Title (EN) SPECIFIC ANTIBODIES AGAINST HUMAN CXCL4 AND USES THEREOF
(FR) ANTICORPS SPÉCIFIQUES DIRIGÉS CONTRE LE CXCL4 HUMAIN ET LEURS UTILISATIONS
Abstract: front page image
(EN)The invention relates to specific antibodies against human CXCL4 and uses thereof. More particularly,the antibodies of the invention maybe used for specifically detecting CXCL4 in a biological sample or as drug, for instance for treating disease associated with pathological angiogenesis when said antibodies are coupled with a cytotoxic agent.
(FR)La présente invention concerne des anticorps spécifiques dirigés contre le CXCL4 humain et leurs utilisations. Plus particulièrement, les anticorps selon l'invention peuvent être utilisés pour la détection spécifique de CXCL4 dans un échantillon biologique ou en tant que médicament pour le traitement de maladie associée à l'angiogenèse pathologique lorsque lesdits anticorps sont couplés à un agent cytotoxique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)